Patient Resources / Pediatric Brain Cancer

When a child faces pediatric brain cancer.

Being told your child has brain or spinal cord cancer is one of the hardest things a family can face. This page is here to help you understand pediatric brain cancer in plain terms, and to point you toward the people and resources that can help.

Cancer in a growing brain.

Pediatric brain cancers are tumors that form in a child’s brain or spinal cord. Cerenome’s research focuses on two types, high-grade glioma and ependymoma, which can grow quickly and be hard to treat. These aren’t simply adult cancers in younger patients: they can be different tumor types, growing in a brain that’s still developing, which shapes both a child’s symptoms and the treatments that can safely be used.

1. American Cancer Society. Key statistics for brain tumors in children. Updated February 9, 2026. Accessed October 7, 2026. https://www.cancer.org/cancer/types/brain-spinal-cord-tumors-children/key-statistics.html

4,900 pediatric brain and spinal cord tumors are diagnosed each year, making it the second most common cancer in children and teens.1

A grid of 4,900 coral dots.
Each dot represents one child or teen diagnosed in a year.

Treating Pediatric Brain Cancer

A developing brain narrows the options.

Treating cancer in a child differs from treating it in an adult, for reasons that shape nearly every option.

A developing brain.

Radiation and some drugs can affect a child’s growth and development, so they can’t be used as freely as in an adult.

The options can be harsh.

Many existing treatments are invasive or hard on a small, growing body.

These cancers are studied less.

Because they’re rare, fewer children take part in trials, and progress has been slower than in more common cancers.

How Cerenome is working on it.

Because a child’s developing brain limits how much radiation can be given broadly, Cerenome is studying a more localized approach. Its investigational radiotherapeutic, REYOBIQ™, is given as a single dose, placed directly into the tumor through convection-enhanced delivery (CED). Its nanoliposome design is built to hold that dose right where it’s placed, concentrating the radiation on the tumor while limiting what reaches the developing brain nearby. It’s being studied in an early-stage (Phase 1) clinical trial called ReSPECT-PBC, the first step in carefully testing a new treatment’s safety.

These are investigational uses. The treatment is still being studied, and its safety and effectiveness have not been established. Your child’s care team is the best guide to whether a clinical trial may be right.

Support & Resources

Where to learn more.

Signs and symptoms in children

Depending on the tumor’s location and the child’s age, pediatric brain cancer can cause headaches, seizures, nausea or vomiting, changes in behavior, balance, or development, and weakness. Any new or worsening symptom is worth raising with your child’s care team.

How it’s diagnosed

Diagnosis usually begins with an MRI, and is confirmed by examining tissue from surgery or a biopsy.

How it’s treated today

Treatment often begins with surgery to remove as much of the tumor as safely possible, sometimes with radiation and/or chemotherapy. For high-grade tumors, options at recurrence have been limited.

Questions to ask your child’s care team
  • Could a clinical trial be an option for my child?
  • What would taking part involve?
  • How would treatment be given, and what should we expect?
Where to find support